NASDAQ:ROIV News 11 December 2025

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.

7 February 2026

NASDAQ:ROIV·Pharmaceuticals·Stock Market

Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts

December 11, 2025 – Roivant Sciences Ltd. (Nasdaq: ROIV) has just given Wall Street a dense dose of biotech optimism. Here’s what today’s Investor Day and the latest data mean for the stock. ROIV stock today: rally near 52‑week highs Roivant shares traded around the low‑$20s on December 11, with intraday prices near $21.5 according to real‑time market data. That move builds on a powerful run: The immediate catalyst for today’s jump: Roivant’s 2025 Investor Day, where management laid out an aggressive roadmap of 3+ potential product launches, 4+ expected NDA/BLA filings, and 8+ pivotal readouts over the next three

11 December 2025

NASDAQ:ROIV

SK hynix stock price slips to 839,000 won as Korea tech selloff bites — what to watch next week

8 February 2026

SK hynix closed Friday down 0.36% at 839,000 won as the KOSPI slid 1.4%, snapping a six-week winning streak. Global DRAM shortages and rising AI demand are pushing memory prices higher, with Apple warning of sharp increases. SK hynix goes ex-dividend on Feb. 26. Seoul’s market reopens Monday, with traders eyeing tech sentiment and memory supply signals.

Micron stock pops 3% into the weekend as UBS calls memory shortage “deeper into 2027”

8 February 2026

Micron shares closed up 3.1% at $394.69 Friday after UBS raised its price target to $450, citing ongoing memory chip shortages. The stock traded between $372.87 and $396.65 on volume of 37.2 million shares. Micron executives are set to speak at a Wolfe Research conference Feb. 11.

ASML stock price jumps on AI-spending rebound — dividend dates and U.S. data ahead

8 February 2026

ASML shares closed up 3.84% in Amsterdam at 1,193.80 euros and rose 4.6% in New York to $1,413.01 on Friday. Chip stocks rebounded as investors bet on continued AI data center spending. ASML’s ex-dividend dates are Feb. 9 in Amsterdam and Feb. 10 in New York. U.S. jobs and inflation data next week may affect tech valuations.

Nvidia stock price jumps nearly 8% on AI spending signals — what to watch before Monday

8 February 2026

Nvidia shares jumped 7.9% to $185.41 Friday, leading chip stocks higher on renewed bets that AI data-center spending by Amazon and Alphabet will surge. The VanEck Semiconductor ETF climbed 5.4%. Investors await U.S. jobs and inflation data next week, then Nvidia’s earnings on Feb. 25.

NASDAQ:ROIV News 11 December 2025 - 7 February 2026

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts

Stock Market Today

SK hynix stock price slips to 839,000 won as Korea tech selloff bites — what to watch next week

Micron stock pops 3% into the weekend as UBS calls memory shortage “deeper into 2027”

ASML stock price jumps on AI-spending rebound — dividend dates and U.S. data ahead

Nvidia stock price jumps nearly 8% on AI spending signals — what to watch before Monday